Gibson Dunn Advises Assertio on Sale to Garda Therapeutics and on Sale of U.S. Sales and Distribution Rights for Portfolio of Seven Branded Products to Cosette Pharmaceuticals

Firm News  |  April 13, 2026

---

Gibson Dunn is advising Assertio Holdings on its sale to Garda Therapeutics.

In addition, Gibson Dunn is advising Assertio on its sale of the U.S. sales and distribution rights for a portfolio of seven branded products to Cosette Pharmaceuticals.

Our corporate team includes partners Ryan Murr, Branden Berns, and Evan D’Amico.